Abstract:Following the publication of the above paper, it was drawn to the Editor's attention by a concerned reader that a large number of data panels showing cell migration and invasion assay data in Figs. 3C and 5 contained overlapping sections, such that data that were intended to show results obtained under different experimental conditions may have been derived from a smaller number of original sources. In addition, certain of the data in this pair of figures were strikingly similar to data that were submitted for publication in another journal at around the same time as the above paper was submitted to Oncology Reports. Finally, regarding the western blotting data shown in Fig. 4B, an obvious splice in the gel strip was noticed for the FBXW7 bands, whereas no equivalent splice was present in the associated GADPH loading control, suggesting that these data originated from different gels. Owing to the fact that the contentious data in the above article were under consideration for publication at around the time that this was submitted to Oncology Reports, in addition the other features of concern regarding the data, the Editor has decided that this paper should be retracted from the Journal on account of a lack of confidence in the presented data. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 38: 3030‑3038, 2017; DOI: 10.3892/or.2017.5995].

[Retracted] miRNA‐490‐3p promotes the metastatic progression of invasive ductal carcinoma

[Retracted] MicroRNA‐329‐3p targets MAPK1 to suppress cell proliferation, migration and invasion in cervical cancer

[Retracted] MicroRNA‐34a expression affects breast cancer invasion in vitro and patient survival via downregulation of E2F1 and E2F3 expression

[Retracted] lncRNA ROR promotes the progression of renal cell carcinoma through the miR‐206/VEGF axis

[Retracted] Upregulation of microRNA‐181b inhibits CCL18‐induced breast cancer cell metastasis and invasion via the NF‐κB signaling pathway

[Retracted] MicroRNA‐19b promotes the migration and invasion of ovarian cancer cells by inhibiting the PTEN/AKT signaling pathway

[Retracted] MicroRNA-124-3p inhibits the growth and metastasis of nasopharyngeal carcinoma cells by targeting STAT3

[Retracted] microRNA‐206 overexpression inhibits cellular proliferation and invasion of estrogen receptor α‐positive ovarian cancer cells

[Retracted] LncRNA TTN‐AS1 promotes endometrial cancer by sponging miR‐376a‐3p

[Retracted] MicroRNA‐320 targets mitogen‐activated protein kinase 1 to inhibit cell proliferation and invasion in epithelial ovarian cancer

[Retracted] Downregulation of microRNA-206 suppresses clear cell renal carcinoma proliferation and invasion by targeting vascular endothelial growth factor A

[Retracted] miR‑25 promotes metastasis via targeting FBXW7 in esophageal squamous cell carcinoma

[Retracted] MicroRNA‐140 represses glioma growth and metastasis by directly targeting ADAM9

[Retracted] MicroRNA‐655 suppresses cell proliferation and invasion in oral squamous cell carcinoma by directly targeting metadherin and regulating the PTEN/AKT pathway

[Retracted] lncRNA DQ786243 promotes hepatocellular carcinoma cell invasion and proliferation by regulating the miR‐15b‐5p/Wnt3A axis

[Retracted] miR‐34a is downregulated in human osteosarcoma stem‐like cells and promotes invasion, tumorigenic ability and self‐renewal capacity

[Retracted] lncRNA‑u50535 promotes the progression of lung cancer by activating CCL20/ERK signaling

[Retracted] MicroRNA‐425 is downregulated in nasopharyngeal carcinoma and regulates tumor cell viability and invasion by targeting hepatoma‐derived growth factor

[Retracted] MicroRNA‑29a inhibits cell migration and invasion by targeting Roundabout 1 in breast cancer cells

[Retracted] MicroRNA‐219 is downregulated in non‐small cell lung cancer and inhibits cell growth and metastasis by targeting HMGA2

[Retracted] miR‐218 functions as a tumor suppressor gene in cervical cancer